Researchers have developed a spinal cord organoid model for SMA, demonstrating marked degeneration of motor neurons within it, which can be prevented with a small molecule inhibitor of CDK4/6.[217] Another study explores the hypothesis of whether developmental defects contribute to postnatal neuronal death in SMA. This evidence concerns the gene CDK4 and proximal spinal muscular atrophy.